Enhanced Housing Photoscreeners 2WIN and GoCheckKids Compared in Burma and Alaska
NCT04068129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 162
Last updated 2020-10-19
Summary
"Adaptica" (Padova, Italy) designed a fixed-distance, dark portable tube with power and remote control for the "2WIN: photoscreener. GoChecksKids designed a flash-concentrating case for the iPhone 7+ to more quickly achieve two-axis photoscreen. These devices were compared to confirmatory exams in children and young adults in a remote Burma clinic and in an Alaskan pediatric ophthalmology practice.
Conditions
- Amblyopia
- Anisometropia
Interventions
- DEVICE
-
photoscreen
Determine amblyopia risk factors
Sponsors & Collaborators
-
Alaska Blind Child Discovery
lead OTHER
Principal Investigators
-
Robert W Arnold, MD · Alaska Blind Child Discovery
Eligibility
- Min Age
- 6 Months
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-02-11
- Primary Completion
- 2019-04-12
- Completion
- 2019-04-15
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Comparison of Visual Acuity Performed in Office Versus In Residence
NCT05250986 ·Status: UNKNOWN
-
Amblyopia Treatment for Children Aged 8 to 12 Years
NCT07281742 ·Status: RECRUITING ·Phase: NA
-
Myopia Preventing With Distance-image Screen
NCT06088225 ·Status: RECRUITING ·Phase: NA
-
Development of Bioluminescent Myopia Prevention and Control Instrument and Evaluation of Its Effect on Myopia
NCT07208617 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dichoptic Video Treatment for Amblyopia
NCT03825107 ·Status: COMPLETED ·Phase: NA
-
Comparative Validation of "Blinq" and "2WIN" Vision Screeners
NCT04195711 ·Status: COMPLETED
-
Tolerability of a Novel Spectacle Design With Reduced Peripheral Contrast
NCT03761758 ·Status: COMPLETED ·Phase: NA
-
The Objective of This Study is to Evaluate the Perfomance of a Photorefraction Device for Screening Ametropia in Children. Eligible Participants Will Undergo Multiple Refractive Error Measurements, Visual Acuity and Strabismus Assessments During a Single Evaluation Visit.
NCT06882408 ·Status: RECRUITING ·Phase: NA
-
Treating Amblyopia With CureSight
NCT06165705 ·Status: RECRUITING ·Phase: NA
-
AR Training Versus Patching in Unilateral Amblyopia
NCT06498206 ·Status: RECRUITING ·Phase: NA
-
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
NCT06524882 ·Status: RECRUITING ·Phase: PHASE3
-
Refractive Accuracy of "2WIN" and Portable Autorefractors
NCT04249505 ·Status: COMPLETED
-
Assessment of Device for Treatment of Amblyopia
NCT02003235 ·Status: COMPLETED ·Phase: NA
-
Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia
NCT00587171 ·Status: TERMINATED ·Phase: PHASE3
-
AR Training in Adults With Unilateral Amblyopia
NCT06704737 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Children's Eye Examination and Testing At Home Study
NCT06980415 ·Status: COMPLETED ·Phase: NA
-
Optimization of a Photoretinoscopy Method for Determining the Objective Refraction of Children With a Smartphone/add-on Device in India
NCT06524115 ·Status: COMPLETED ·Phase: NA
-
OKKO Space Academy to Check Children's Vision at Home
NCT05313516 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Exploring Perceptual Learning in Blurred Gabor Discrimination for Low-Myopic Children
NCT07107646 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
NCT06429280 ·Status: RECRUITING
-
Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children
NCT00091923 ·Status: COMPLETED ·Phase: PHASE3
-
A Patch Free Treatment for Young Children With Amblyopia
NCT04086524 ·Status: COMPLETED ·Phase: NA
-
The Children's WEAR Trial(Phase 1&2)
NCT01704729 ·Status: COMPLETED ·Phase: NA
-
Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old
NCT00315198 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Visual Screening in Ontario
NCT02458846 ·Status: COMPLETED ·Phase: NA